muramylnac-ala-isogln-lys-tripeptide has been researched along with Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, KL; Fidler, IJ; Fogler, WE; Kleinerman, ES; Schroit, AJ | 1 |
1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Carcinoma; Cells, Cultured; Cytotoxicity, Immunologic; Humans; Kidney; Liposomes; Lung; Macrophage Activation; Melanoma; Monocytes; Phagocytosis | 1983 |